Published in Bone on October 01, 2001
Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study. Osteoporos Int (2012) 3.13
Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg (2008) 2.25
Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts. J Oral Maxillofac Surg (2011) 1.50
Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci (2011) 1.22
The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K-Akt-NFkappaB pathway in osteosarcoma cells. Br J Pharmacol (2005) 0.95
The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study. Clin Oral Investig (2011) 0.95
Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect. Vasc Cell (2013) 0.93
Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice. BMC Cancer (2008) 0.90
Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells. J Cell Mol Med (2008) 0.86
Effects of pamidronate on human alveolar osteoblasts in vitro. J Oral Maxillofac Surg (2012) 0.86
Development of oral osteomucosal tissue constructs in vitro and localization of fluorescently-labeled bisphosphonates to hard and soft tissue. Int J Mol Med (2014) 0.84
Bisphosphonate use and risk of colorectal cancer: a systematic review and meta-analysis. Br J Clin Pharmacol (2013) 0.84
Aspiration of alendronic acid leading to localized bronchiectasis. Eur J Clin Pharmacol (2011) 0.84
Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells. Br J Cancer (2004) 0.82
The susceptive alendronate-treatment timing and dosage for osteogenesis enhancement in human bone marrow-derived stem cells. PLoS One (2014) 0.81
Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment. Int J Dent (2014) 0.81
Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines. BMC Cancer (2007) 0.80
Oral bisphosphonates and colon cancer: an update. Ther Adv Musculoskelet Dis (2015) 0.80
Bisphosphonates inhibit expression of p63 by oral keratinocytes. J Dent Res (2011) 0.79
Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment. Clin Interv Aging (2009) 0.78
Pamidronate Down-regulates Tumor Necrosis Factor-alpha Induced Matrix Metalloproteinases Expression in Human Intervertebral Disc Cells. J Bone Metab (2016) 0.75
Post-diagnostic oral bisphosphonate use and colorectal cancer mortality: a population-based cohort study within the UK Clinical Practice Research Datalink. Br J Cancer (2015) 0.75
Chemical injury caused by acute alendronic acid aspiration. BMJ Case Rep (2014) 0.75
Bisphosphonates and atypical subtrochanteric fractures of the femur. Bone Joint Res (2017) 0.75
Efficient Transdermal Delivery of Alendronate, a Nitrogen-Containing Bisphosphonate, Using Tip-Loaded Self-Dissolving Microneedle Arrays for the Treatment of Osteoporosis. Pharmaceutics (2017) 0.75
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int (2008) 4.73
Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res (1998) 3.65
Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther (2001) 3.59
Construction of the mycoplasma evolutionary tree from 5S rRNA sequence data. Proc Natl Acad Sci U S A (1985) 3.38
Purification and properties of rat liver microsomal stearyl coenzyme A desaturase. Proc Natl Acad Sci U S A (1974) 3.18
Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone (2005) 3.13
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A (1999) 2.66
Bisphosphonates: from the laboratory to the clinic and back again. Bone (1999) 2.55
Anticodon and acceptor stem nucleotides in tRNA(Gln) are major recognition elements for E. coli glutaminyl-tRNA synthetase. Nature (1991) 2.39
Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. Proc Natl Acad Sci U S A (1996) 2.35
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity. Br J Haematol (1997) 2.14
Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia (2009) 2.11
Plasmodium: genus-conserved primers for species identification and quantitation. Exp Parasitol (1995) 1.81
Identifying the speech codes. Cogn Psychol (1980) 1.73
Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res (1997) 1.72
The binding of cytochrome b 5 to liver microsomes. J Biol Chem (1972) 1.71
Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res (2000) 1.70
Strontium ranelate does not stimulate bone formation in ovariectomized rats. Osteoporos Int (2008) 1.61
The composition of tracheal mucus and the nervous control of its secretion in the cat. Proc R Soc Lond B Biol Sci (1975) 1.58
The cytoplasmic ribosomal RNAs of Plasmodium spp. Parasitol Today (1995) 1.56
Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton. J Biol Chem (1997) 1.51
Lipid-protein interactions in the reconstitution of the microsomal reduced nicotinamide adenine dinucleotide-cytochrome b 5 reductase system. J Biol Chem (1973) 1.49
Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol (1999) 1.48
Apparent dependence of interactions between cytochrome b5 and cytochrome b5 reductase upon translational diffusion in dimyristoyl lecithin liposomes. Proc Natl Acad Sci U S A (1975) 1.46
A Spiroplasma tRNA gene cluster. Isr J Med Sci (1984) 1.44
Allograft with unrelated donor accentuates the gastrointestinal toxicity associated with high-dose melphalan and total body irradiation preparative for bone marrow transplantation in children. Pediatr Transplant (2000) 1.39
The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. Cancer Res (1998) 1.39
Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. Gastroenterology (2000) 1.39
Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des (2010) 1.37
Sympathomimetic drugs stimulate the output of secretory glycoproteins from human bronchi in vitro. Clin Sci (Lond) (1982) 1.36
Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages. J Bone Miner Res (1998) 1.36
Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone (2001) 1.35
Molecular mechanisms of action of bisphosphonates. Bone (1999) 1.33
Regulation and trafficking of three distinct 18 S ribosomal RNAs during development of the malaria parasite. J Mol Biol (1997) 1.33
Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study. Aliment Pharmacol Ther (2006) 1.32
Recognition of bases in Escherichia coli tRNA(Gln) by glutaminyl-tRNA synthetase: a complete identity set. EMBO J (1992) 1.31
The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum (2001) 1.31
Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporos Int (1999) 1.31
The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res (1999) 1.30
The effects of irritation at various levels of the airway upon tracheal mucus secretion in the cat. J Physiol (1976) 1.29
Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro. Pharm Res (1995) 1.29
Effects of target monitoring on understanding fluent speech. Percept Psychophys (1981) 1.27
Control of mucus secretion and ion transport in airways. Annu Rev Physiol (1979) 1.27
Control of nasal vasculature and airflow resistance in the dog. J Physiol (1984) 1.27
Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem (2001) 1.22
Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. Mol Pharmacol (1996) 1.19
The roles of mediators, irritants and allergens in causing mucin secretion from the trachea. Ciba Found Symp (1978) 1.15
Measuring lexical access during sentence processing. Percept Psychophys (1980) 1.11
The nucleotide sequence of the 5S rRNA from Spiroplasma species BC3 and Mycoplasma mycoides sp. capri PG3. Nucleic Acids Res (1982) 1.10
Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesis. J Biol Chem (2000) 1.08
Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium. Clin Chem (2000) 1.08
The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma. Br J Haematol (2000) 1.06
Competition of aminoacyl-tRNA synthetases for tRNA ensures the accuracy of aminoacylation. Nucleic Acids Res (1992) 1.05
Effects of interruption of apicoplast function on malaria infection, development, and transmission. Mol Biochem Parasitol (2000) 1.05
Evidence for randon distribution and translational movement of cytochrome b5 in endoplasmic reticulum. J Biol Chem (1974) 1.04
Synthetase competition and tRNA context determine the in vivo identify of tRNA discriminator mutants. J Mol Biol (1992) 1.04
Transfer RNA-dependent cognate amino acid recognition by an aminoacyl-tRNA synthetase. EMBO J (1996) 1.03
Effect of alpha-adrenergic stimulation on mucus secretion and on ion transport in cat trachea in vitro. Am Rev Respir Dis (1980) 1.03
The anatomy, physiology, pharmacology and pathology of tracheobronchial mucus secretion and the use of expectorant drugs in human disease. Pharmacol Ther B (1978) 1.03
Qa alloantigen expression on functional T lymphocytes from spleen and thymus. Immunogenetics (1986) 1.02
Mucus-glycoproteins (mucins) of the cat trachea: characterisation and control of secretion. Biochim Biophys Acta (1986) 1.02
The role of prenylated small GTP-binding proteins in the regulation of osteoclast function. Calcif Tissue Int (2002) 1.00
Tumor antigens on neoplasms induced by chemical carcinogens and by DNA- and RNA-containing viruses: properties of the solubilized antigens. Adv Cancer Res (1980) 1.00
Effect of peripheral nerve section and nerve crush on spinal cord neuropeptides in the rat; increased VIP and PHI in the dorsal horn. Neuroscience (1984) 0.99
Combined study to assess the role of calcium alginate swabs and ligation of the inferior tonsillar pole in the control of intra-operative blood loss during tonsillectomy. J Laryngol Otol (1991) 0.99
Separation of the tumor rejection antigen (TSTA) from the major viral structural proteins associated with the membrance of an R-MuLV-induced leukemia. Int J Cancer (1978) 0.99
Streptomyces spores from mouldy houses induce nitric oxide, TNFα and IL-6 secretion from RAW264.7 macrophage cell line without causing subsequent cell death. Environ Toxicol Pharmacol (1997) 0.99
Interaction of liposomes with human skin in vitro--the influence of lipid composition and structure. Biochim Biophys Acta (1996) 0.98
A peptide prodrug approach for improving bisphosphonate oral absorption. J Med Chem (2000) 0.98
Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa. Dig Dis Sci (2000) 0.98
Interaction of halide ions with Aspergillus niger glucose oxidase. Biochemistry (1971) 0.97
The nucleotide sequence of a tRNA gene cluster from Spiroplasma meliferum. Nucleic Acids Res (1986) 0.97
Differences between bisphosphonates in binding affinities for hydroxyapatite. J Biomed Mater Res B Appl Biomater (2010) 0.96
Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs. Mol Pharmacol (1998) 0.95
Plasmodium: the developmentally regulated ribosome. Exp Parasitol (1994) 0.95
Nonclinical model for assessing gastric effects of bisphosphonates. Dig Dis Sci (1997) 0.95
Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. Eur J Pharm Sci (1999) 0.94
Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis (1999) 0.94
Subcellular distribution of the tumor-specific transplantation antigen of simian virus 40-transformed cells. J Natl Cancer Inst (1977) 0.94
A novel method for efficient generation of transfected human osteoclasts. Calcif Tissue Int (2007) 0.94
The interaction of NADH-cytochrome b5 reductase and cytochrome b5 bound to egg lecithin liposomes. J Biol Chem (1975) 0.93
Comparison of MHC genes among distantly related members of the genus Mus. J Immunol (1985) 0.93
Inhibition of growth of Dictyostelium discoideum amoebae by bisphosphonate drugs is dependent on cellular uptake. Pharm Res (1997) 0.92
Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl (1997) 0.91
Alendronate disturbs vesicular trafficking in osteoclasts. Calcif Tissue Int (2001) 0.91
The peptide VIP is a neurotransmitter in rat adrenal medulla: physiological role in controlling catecholamine secretion. J Physiol (1991) 0.91
Biochemical analysis of a 40,000 mol. wt mouse serum protein which binds beta 2-microglobulin and has serological cross-reactivity with H-2 antigens. Mol Immunol (1982) 0.91
Effects of VIIth (facial) nerve degeneration on vasoactive intestinal polypeptide and substance P levels in ocular and orbital tissues of the rabbit. Exp Eye Res (1984) 0.91
Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonates. Life Sci (2003) 0.91
N-bisphosphonates cause gastric epithelial injury independent of effects on the microcirculation. Aliment Pharmacol Ther (1999) 0.91
Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion. Int J Immunopharmacol (1995) 0.90
Mutant enzymes and tRNAs as probes of the glutaminyl-tRNA synthetase: tRNA(Gln) interaction. Biochimie (1991) 0.90
Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Control Release (1999) 0.90